May 24, 2017
$1 billion increase from 2014-15 fueled largely by new, higher-cost drugs
May 16, 2017
Statement from Patented Medicine Prices Review Board Vice-chairperson Dr. Mitchell Levine on the launch of Health Canada’s consultation on potential changes to the Patented Medicines Regulations.
April 12, 2017
Proceedings to resume April 18, 2017 in Ottawa.
April 11, 2017
The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, today published the first edition of Meds Entry Watch, a new annual publication that provides information on recently launched drugs in Canada and select international markets.
February 15, 2017
Proceedings to resume February 20, 2017 in Ottawa.